project id: TCGA-LGG; case submitter id: TCGA-RY-A840; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.53; rna integrity number: 7.9; age at index: 47; days to birth: -17501; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1965; age at diagnosis: 17501; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 854.0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9451/3; primary diagnosis: Oligodendroglioma, anaplastic; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 444; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-RY-A840-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 35.0; percent tumor cells: 55.0; percent tumor nuclei: 90.0;